Aarti Drugs Ltd share price logo

Aarti Drugs Ltd Share Price

(AARTIDRUGS)

₹340.33.63%

as on 04:01PM, 28 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Aarti Drugs Ltd Performance

  • Day's Low

    Day's High

    ₹338.2
    Day's Price Range
    ₹360
  • 52 Week's Low

    52 Week's High

    ₹330.05
    52-Week Price Range
    ₹635
1 Month Return-1.29 %
3 Month Return-26.19 %
1 Year Return-25.6 %
Previous Close₹353.10
Open₹353.00
Volume2.65L
Upper Circuit₹423.70
Lower Circuit₹282.50
Market Cap₹3,128.55Cr

Aarti Drugs Ltd Fundamentals

P/E Ratio

20.43

PEG Ratio

-7.12

Market Cap

₹3,128.55 Cr

P/B Ratio

3.39

EPS

18.66

Dividend Yield

0.23

Sector

Pharmaceuticals

ROE

12.39

Aarti Drugs Ltd Analyst Rating

based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts offering long term price targets for Aarti Drugs Ltd. An average target of ₹465

Source: S&P Global Market Intelligence

Aarti Drugs Ltd Share analysis

Aarti Drugs Ltd price forecast by 1 analysts

Upside of36.64%

High

₹465

Target

₹465.00

Low

₹465

Aarti Drugs Ltd target price ₹465, a slight upside of 36.64% compared to current price of ₹340.3. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Key events for Aarti Drugs Ltd

  • Aarti Drugs Shares Hit 52-Week Low - 13 Mar, 2025

    Aarti Drugs Ltd shares fell 2.2% to a 52-week low of ₹332.60, marking a 9% decline over five sessions and 26% over the past year. Despite a modest 1.1% increase in net profit to ₹37.1 crore for Q4 2024, revenue dropped 8.1% year-over-year to ₹556.6 crore.
  • Aarti Drugs Warned by SEBI for Insider Trading - 07 Mar, 2025

    Aarti Drugs Ltd has received an administrative warning letter from SEBI for violations related to insider trading regulations, raising concerns about compliance.
  • Aarti Drugs Cleared by US FDA for Exports - 14 Feb, 2025

    Aarti Drugs Limited has been removed from the US FDA Import Alert 66-40, allowing the company to resume exports to the US market. This follows successful inspections and satisfactory responses to FDA concerns. The clearance enables Aarti to export key pharmaceutical products without restrictions, marking a significant boost for the company.

Insights on Aarti Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 6.25% to 7.78% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 33.24 Cr → 37.05 Cr (in ₹), with an average increase of 5.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 70.5% return, outperforming this stock by 89.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 154.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 34.02% to 33.57% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, AARTIDRUGS stock has moved down by -17.3%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 55.64% to 55.38% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.50% to 2.28% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 599.81 Cr → 568.5 Cr (in ₹), with an average decrease of 5.2% per quarter

Aarti Drugs Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹605.94Cr (-)₹619.99Cr (↑2.32%)₹555.34Cr (↓10.43%)₹598.33Cr (↑7.74%)₹556.60Cr (↓6.97%)
Net Income₹36.71Cr (-)₹47.31Cr (↑28.87%)₹33.27Cr (↓29.68%)₹34.96Cr (↑5.08%)₹37.09Cr (↑6.09%)
Net Profit Margin6.06% (-)7.63% (↑25.91%)5.99% (↓21.49%)5.84% (↓2.50%)6.66% (↑14.04%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,637.00Cr (-)₹2,034.51Cr (↑24.28%)₹2,195.49Cr (↑7.91%)₹2,171.63Cr (↓1.09%)
Total Liabilities₹777.39Cr (-)₹1,062.34Cr (↑36.65%)₹1,081.19Cr (↑1.77%)₹996.42Cr (↓7.84%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹196.15Cr (-)₹154.18Cr (↓21.40%)₹39.90Cr (↓74.12%)₹161.70Cr (↑305.26%)₹337.10Cr (↑108.47%)

Aarti Drugs Ltd Index Inclusions

BSE Healthcare

₹41,421.50

-0.12 (-48.19%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹46,638.13

-0.35 (-165.52%)

Aarti Drugs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
55.38%
-0.47
Foreign Institutions
2.28%
-8.79
Mutual Funds
7.78%
24.40
Retail Investors
33.57%
-1.32
Others
0.99%
-37.57

Aarti Drugs Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)15.1730.0922.1417.9718.66
Details20202021202220232024
Return On Equity %23.7934.7921.2914.6512.39
Details20202021202220232024
Return On Assets %9.6117.1310.087.587.89
Details20202021202220232024
Book Value Per Share (₹)70.0198.01111.92128.77139.4

Aarti Drugs Ltd Valuation

Aarti Drugs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.29x)

March 31, 2020

Today (20.43x)

March 28, 2025

Industry (53.18x)

March 28, 2025

Highest (57.24x)

August 24, 2020

LowHigh

Aarti Drugs Ltd Earnings and Dividends

  • Aarti Drugs Ltd Earnings Results

    Aarti Drugs Ltd’s net profit jumped 1.04% since last year same period to ₹37.05Cr in the Q3 2024-2025. On a quarterly growth basis, Aarti Drugs Ltd has generated 5.83% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Aarti Drugs Ltd Dividends January,2025

    In the quarter ending December 2024, Aarti Drugs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.29%.

    Read More about Dividends

Aarti Drugs Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Aarti Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.

Aarti Drugs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹3,128.55 Cr35.84%0.64₹171 Cr₹2,528 Cr
BUY₹29,300.43 Cr221.22%0.52₹300 Cr₹1,051 Cr
BUY₹14,271.69 Cr68.11%0.57₹72 Cr₹6,702 Cr
NA₹4,800.00 Cr13.52%0.79-₹388 Cr₹75 Cr
BUY₹14,234.50 Cr42.27%0.68₹218 Cr₹1,296 Cr

About Aarti Drugs Ltd

Aarti Drugs Limited is a leading manufacturer of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals. Part of the USD 1500 million Aarti Group, it has two RD divisions in Tarapur and Turbhe, Maharashtra; and three wholly-owned subsidiaries, namely Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA, a foreign subsidiary. It has expanded its production capacity from 598,000kg in 1993 to 25,716,000kg in 2021. In 2020 it incorporated two overseas subsidiaries and one domestic one, while the one in 2021 was wound up as it didn’t have any business activity. Aarti Drugs also carries out research and development on key products such as antihistaminic/antiallergic, antiinflammatory and antidiabetic. Its GMP-certified plant can manufacture Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. With 50 compounds formed for Antibiotics, Anti Protozoal, AntiInflammatory, Antidiabetic, Anti Fungal and Cardioprotectant therapeutic segments, it is a market leader in API segment.

Revenue: ₹556.60Cr as on December 2024 (Q4 24)
Net Profit: ₹37.09Cr as on December 2024 (Q4 24)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
OrganisationAarti Drugs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Aarti Drugs Ltd

What is Aarti Drugs Ltd price today?

Aarti Drugs Ltd share price today stands at ₹340.3, Open: ₹353, Previous Close: ₹353.1, High: ₹360, Low: ₹338.2, 52 Week High: ₹635, 52 Week Low: ₹330.05.

How to Buy Aarti Drugs Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Aarti Drugs Ltd shares

What are today's traded volumes of Aarti Drugs Ltd?

Today's traded volume of Aarti Drugs Ltd(AARTIDRUGS) is 2.65L.

What is today's market capitalisation of Aarti Drugs Ltd?

Today's market capitalisation of Aarti Drugs Ltd(AARTIDRUGS) is ₹3128.55Cr.

What is the 52 Week High and Low Range of Aarti Drugs Ltd?

Aarti Drugs Ltd (AARTIDRUGS)
Price
52 Week High
₹635
52 Week Low
₹330.05

How much percentage Aarti Drugs Ltd is down from its 52 Week High?

Aarti Drugs Ltd (AARTIDRUGS) share price is ₹340.3. It is down -46.41% from its 52 Week High price of ₹635

How much percentage Aarti Drugs Ltd is up from its 52 Week low?

Aarti Drugs Ltd (AARTIDRUGS) share price is ₹340.3. It is up 3.11% from its 52 Week Low price of ₹330.05